Atomo and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America
SYDNEY: Atomo Diagnostics has signed a binding agreement with US-based diagnostics specialist Access Bio Inc., that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access Bio for use with its rapid test strip for detection…